A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue

J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e537-e539. doi: 10.1111/jdv.16664. Epub 2020 Jul 2.

Authors

I Torres-Navarro¹, C Abril-Pérez¹, J Roca-Ginés¹, J Sánchez-Arráez¹, R Botella-Estrada^{1

2}

Affiliations

¹ Dermatology Department. Hospital, Universitario y Politécnico La Fe. Valencia, Spain.
² School of Medicine, Universitat de València, Valencia, Spain.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acute Generalized Exanthematous Pustulosis / diagnosis
Acute Generalized Exanthematous Pustulosis / drug therapy
Acute Generalized Exanthematous Pustulosis / etiology*
Adrenal Cortex Hormones / therapeutic use
Biopsy, Needle
COVID-19
COVID-19 Testing
Cephalosporins / adverse effects*
Cephalosporins / therapeutic use
Clinical Laboratory Techniques
Coronavirus Infections / diagnosis*
Coronavirus Infections / drug therapy*
Diagnosis, Differential
Female
Follow-Up Studies
Humans
Immunohistochemistry
Middle Aged
Obesity, Morbid
Pandemics / statistics & numerical data
Pneumonia, Viral / diagnosis*
Pneumonia, Viral / drug therapy*
Severe Acute Respiratory Syndrome / diagnosis
Severe Acute Respiratory Syndrome / drug therapy*
Severity of Illness Index
Treatment Outcome

Substances

Adrenal Cortex Hormones
Cephalosporins
cefditoren